COVID-19 vaccination in mainland China
http://dbpedia.org/resource/COVID-19_vaccination_in_mainland_China
COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region. As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose.
rdf:langString
中国大陆2019冠状病毒病疫苗接种计划，是指由中华人民共和国大陆的各地区执行的2019冠状病毒病疫苗大规模接种计划，其目标为符合条件的民众，可以到经当地卫生健康行政部门设置的接种地点免费接种疫苗，在人群中逐步建立起免疫屏障，以阻断2019冠状病毒病的流行。截至2021年6月，中国大陆共有7款疫苗批准附条件上市或紧急使用，可以供接种单位接种。2021年3月，启动针对海外中国公民的春苗行动。
rdf:langString
rdf:langString
COVID-19 vaccination in mainland China
rdf:langString
中国大陆2019冠状病毒病疫苗接种计划
xsd:integer
68017962
xsd:integer
1124734789
rdf:langString
COVID-19 vaccine doses administered in mainland China.
xsd:date
2020-07-22
rdf:langString
Immunization against COVID-19
rdf:langString
COVID-19 vaccination in mainland China
rdf:langString
COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region. As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose.
rdf:langString
中国大陆2019冠状病毒病疫苗接种计划，是指由中华人民共和国大陆的各地区执行的2019冠状病毒病疫苗大规模接种计划，其目标为符合条件的民众，可以到经当地卫生健康行政部门设置的接种地点免费接种疫苗，在人群中逐步建立起免疫屏障，以阻断2019冠状病毒病的流行。截至2021年6月，中国大陆共有7款疫苗批准附条件上市或紧急使用，可以供接种单位接种。2021年3月，启动针对海外中国公民的春苗行动。
xsd:nonNegativeInteger
30763